Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Henry

Showing results (961-970 of 997) with videos related to

Pageof 100
Sort By:
Nature|June 10, 2005
Brevetoxicosis: red tides and marine mammal mortalitiesLeanne J Flewelling, Jerome P Naar, Jay P Abbott, et al.
Journal of Medicinal Chemistry|January 20, 2018
Synthesis and Pharmacological Characterization of C4<sub>β</sub>-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu<sub>3</sub> Receptor AgonistJames A Monn, Steven S Henry, Steven M Massey, et al.
Journal of Psychosomatic Research|June 11, 2020
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patientsBrett D Thombs, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The Lancet. Rheumatology|April 26, 2021
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trialBrett D Thombs, Linda Kwakkenbos, Brooke Levis, et al.
Nucleic Acids Research|December 1, 2016
Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource CenterAlice R Wattam, James J Davis, Rida Assaf, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
JCI Insight|December 21, 2023
Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthmaBrendan K Huang, Brett M Elicker, Travis S Henry, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 2, 2017
Making stillbirths visible: a systematic review of globally reported causes of stillbirthH E Reinebrant, S H Leisher, M Coory, et al.
Nature Communications|January 27, 2026
Ether lipids influence cancer cell fate by modulating iron uptakeRyan P Mansell, Sebastian Müller, Jia-Shu Yang, et al.
Nature Biotechnology|November 19, 2020
Publisher Correction: A genomic catalog of Earth's microbiomesStephen Nayfach, Simon Roux, Rekha Seshadri, et al.
Pageof 100

Showing results (961-970 of 997) with videos related to

Sort By:
Pageof 100
Nature|June 10, 2005
Brevetoxicosis: red tides and marine mammal mortalitiesLeanne J Flewelling, Jerome P Naar, Jay P Abbott, et al.
Journal of Medicinal Chemistry|January 20, 2018
Synthesis and Pharmacological Characterization of C4<sub>β</sub>-Amide-Substituted 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-Amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2794193), a Highly Potent and Selective mGlu<sub>3</sub> Receptor AgonistJames A Monn, Steven S Henry, Steven M Massey, et al.
Journal of Psychosomatic Research|June 11, 2020
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patientsBrett D Thombs, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The Lancet. Rheumatology|April 26, 2021
Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trialBrett D Thombs, Linda Kwakkenbos, Brooke Levis, et al.
Nucleic Acids Research|December 1, 2016
Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource CenterAlice R Wattam, James J Davis, Rida Assaf, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
JCI Insight|December 21, 2023
Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthmaBrendan K Huang, Brett M Elicker, Travis S Henry, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 2, 2017
Making stillbirths visible: a systematic review of globally reported causes of stillbirthH E Reinebrant, S H Leisher, M Coory, et al.
Nature Communications|January 27, 2026
Ether lipids influence cancer cell fate by modulating iron uptakeRyan P Mansell, Sebastian Müller, Jia-Shu Yang, et al.
Nature Biotechnology|November 19, 2020
Publisher Correction: A genomic catalog of Earth's microbiomesStephen Nayfach, Simon Roux, Rekha Seshadri, et al.
Pageof 100